1,136 hedge funds and large institutions have $30.4B invested in Xylem in 2025 Q4 according to their latest regulatory filings, with 144 funds opening new positions, 410 increasing their positions, 375 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more first-time investments, than exits

New positions opened: 144 | Existing positions closed: 74

72% more call options, than puts

Call options by funds: $35.4M | Put options by funds: $20.6M

61% more capital inflows, than outflows

Capital inflows: $2.26B | Capital outflows: $1.41B

5% more funds holding

Funds holding: 1,086 → 1,136 (+50)

2.04% more ownership

Funds ownership: 89.48% → 91.52% (+2%)

9% more repeat investments, than reductions

Existing positions increased: 410 | Existing positions reduced: 375

8% less funds holding in top 10

Funds holding in top 10: 13 → 12 (-1)

Holders
1,136
Holders Change
+50
Holders Change %
+4.6%
% of All Funds
13.71%
Holding in Top 10
12
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.69%
% of All Funds
0.14%
New
144
Increased
410
Reduced
375
Closed
74
Calls
$35.4M
Puts
$20.6M
Net Calls
+$14.8M
Net Calls Change
+$10.7M

XYL Hedge Fund Activity: Q4 2025 in Review

1,136 of the 8,287 institutional investors tracked by Wall St. Rank reported a position in Xylem (XYL) for Q4 2025, worth a combined $30.4B — down 5.5% from $32.1B a quarter earlier.

Buyers outnumbered sellers: 144 funds opened new XYL positions and 74 closed out — a net gain of 70 holders — while 410 added to existing stakes and 375 trimmed.

The largest buyer was BNP Paribas Asset Management, adding an estimated $130M. The largest seller was T. Rowe Price Associates, cutting an estimated $109M.

  • 1,136 institutional investors held Xylem (XYL) as of Q4 2025, up from 1,086 in Q3 2025.
  • Funds reported $30.4B of Xylem stock for Q4 2025, down 5.5% quarter-over-quarter.
  • 144 funds opened new Xylem positions in Q4 2025 and 74 closed out, a net change of +70 holders.
  • The largest Xylem buyer in Q4 2025 was BNP Paribas Asset Management, an estimated $130M added.
  • The largest Xylem seller in Q4 2025 was T. Rowe Price Associates, an estimated $109M sold.

Based on aggregated 13F filings for Q4 2025.